N4 Pharma (LON:N4P) Shares Up 24.8% – What’s Next?

N4 Pharma Plc (LON:N4P) shares were up 24.8% on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.66 ($0.01). Approximately 8,658,934 shares were traded during mid-day trading, an increase of 318% from the average daily volume of 2,072,280 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Stock Up 2.2 %

The company’s fifty day simple moving average is GBX 0.62 and its 200-day simple moving average is GBX 0.57. The company has a debt-to-equity ratio of 1.62, a current ratio of 22.73 and a quick ratio of 7.28. The firm has a market capitalization of £2.42 million, a PE ratio of -55.00 and a beta of -0.37.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.